Stuttgart - Delayed Quote EUR

DanCann Pharma AS (DAN.SG)

0.0002

0.0000

(0.00%)

At close: 8:05:46 AM GMT+1

Key Events

Loading Chart for DAN.SG

9/21 12:03 PM

DELL

Previous Close 0.0002
Open 0.0002
Bid 0.0002 x --
Ask 0.0006 x --
Day's Range 0.0002 - 0.0002
52 Week Range 0.0002 - 0.0104
Volume 0
Avg. Volume 0
Market Cap (intraday) --
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date Feb 26, 2025 - Mar 3, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

OMX Stockholm 30 Index

.

YTD Return

DAN.SG

0.00%

OMX Stockholm 30 Index

1.53%

1-Year Return

DAN.SG

97.92%

OMX Stockholm 30 Index

7.01%

3-Year Return

DAN.SG

97.92%

OMX Stockholm 30 Index

5.14%

5-Year Return

DAN.SG

97.92%

OMX Stockholm 30 Index

40.81%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

DanCann Pharma AS

0.0002

0.00%

Mkt Cap EUR -

Industry Drug Manufacturers—Specialty & Generic

Gabather AB (publ)

0.5260

-4.36%

Mkt Cap SEK 12.476M

Industry Drug Manufacturers—Specialty & Generic

Klaria Pharma Holding AB (publ.)

0.6140

-8.36%

Mkt Cap SEK 79.672M

Industry Drug Manufacturers—Specialty & Generic

PEPTONIC Medical AB

0.0034

-5.56%

Mkt Cap SEK 19.582M

Industry Drug Manufacturers—Specialty & Generic

0.2645

-0.19%

Mkt Cap SEK 142.312M

Industry Drug Manufacturers—Specialty & Generic

China SXT Pharmaceuticals, Inc.

0.4023

-2.47%

Mkt Cap 1.634M

Industry Drug Manufacturers—Specialty & Generic

Nanexa AB (publ)

2.2200

+1.37%

Mkt Cap SEK 301.245M

Industry Drug Manufacturers—Specialty & Generic

Procaps Group S.A.

1.7600

+4.76%

Mkt Cap 198.57M

Industry Drug Manufacturers—Specialty & Generic

InMed Pharmaceuticals Inc.

4.0800

-4.90%

Mkt Cap 2.955M

Industry Drug Manufacturers—Specialty & Generic

Petros Pharmaceuticals, Inc.

0.3105

-10.00%

Mkt Cap 3.11M

Industry Drug Manufacturers—Specialty & Generic

Universe Pharmaceuticals INC

0.5400

+3.85%

Mkt Cap 1.136M

Industry Drug Manufacturers—Specialty & Generic

Valuation Measures

As of 1/13/2025

Market Cap

1.18M
Enterprise Value

1.15M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

0.28
Price/Book (mrq)

0.45
Enterprise Value/Revenue

1.03
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

--
Return on Assets (ttm)

--
Return on Equity (ttm)

--
Revenue (ttm)

--
Net Income Avi to Common (ttm)

--
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

--
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

--